Fortrea Holdings, Inc. (FTRE)
17.20
+0.18
(+1.06%)
USD |
NASDAQ |
Sep 11, 16:00
17.19
-0.01
(-0.06%)
After-Hours: 20:00
Fortrea Holdings Enterprise Value : 2.585B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.585B |
| September 10, 2026 | 2.568B |
| September 09, 2026 | 2.546B |
| September 08, 2026 | 2.571B |
| September 04, 2026 | 2.632B |
| September 03, 2026 | 2.720B |
| September 02, 2026 | 2.695B |
| September 01, 2026 | 2.634B |
| August 31, 2026 | 2.696B |
| August 28, 2026 | 2.738B |
| August 27, 2026 | 2.742B |
| August 26, 2026 | 2.711B |
| August 25, 2026 | 2.686B |
| August 24, 2026 | 2.690B |
| August 21, 2026 | 2.698B |
| August 20, 2026 | 2.679B |
| August 19, 2026 | 2.674B |
| August 18, 2026 | 2.623B |
| August 17, 2026 | 2.670B |
| August 14, 2026 | 2.605B |
| August 13, 2026 | 2.644B |
| August 12, 2026 | 2.692B |
| August 11, 2026 | 2.805B |
| August 10, 2026 | 2.755B |
| August 07, 2026 | 2.702B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.631B |
| August 05, 2026 | 2.761B |
| August 04, 2026 | 2.660B |
| August 03, 2026 | 2.750B |
| July 31, 2026 | 2.772B |
| July 30, 2026 | 2.763B |
| July 29, 2026 | 2.889B |
| July 28, 2026 | 2.917B |
| July 27, 2026 | 2.775B |
| July 24, 2026 | 2.805B |
| July 23, 2026 | 2.803B |
| July 22, 2026 | 2.707B |
| July 21, 2026 | 2.652B |
| July 20, 2026 | 2.635B |
| July 17, 2026 | 2.638B |
| July 16, 2026 | 2.653B |
| July 15, 2026 | 2.652B |
| July 14, 2026 | 2.664B |
| July 13, 2026 | 2.647B |
| July 10, 2026 | 2.638B |
| July 09, 2026 | 2.629B |
| July 08, 2026 | 2.568B |
| July 07, 2026 | 2.611B |
| July 06, 2026 | 2.646B |
| July 02, 2026 | 2.592B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Charles River Laboratories International, Inc. | 16.15B |
| IQVIA Holdings, Inc. | 57.38B |
| Medpace Holdings, Inc. | 16.00B |
| Personalis, Inc. | 1.550B |
| 10X Genomics, Inc. | 8.463B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.20M |
| Revenue (Quarterly) | 678.20M |
| Total Expenses (Quarterly) | 691.40M |
| EPS Diluted (Quarterly) | -0.1392 |
| Gross Profit Margin (Quarterly) | 17.63% |
| Profit Margin (Quarterly) | -1.95% |
| Earnings Yield | -5.32% |
| Operating Earnings Yield | 1.62% |
| Normalized Earnings Yield | -3.684 |